28370352|t|Serum levels of genomic DNA of α1(I) collagen are elevated in scleroderma patients
28370352|a|Recent studies have indicated that various nucleic acids are present in human sera, and attracted attention for their potential as novel disease markers in many human diseases. In this study, we tried to evaluate the possibility that DNA and RNA of collagens exist in human sera, and determined whether their serum levels can be useful biomarkers in scleroderma patients. The RNA or DNA of collagens were purified from sera, and detected by polymerase chain reaction or quantitated by real-time polymerase chain reaction. Among approximately 18 360 bases of full-length α1(I) collagen DNA, various regions were detected by polymerase chain reaction in human sera. However, α2(I) collagen DNA, α1(I) collagen RNA or α2(I) collagen RNA were not detectable. α1(I) Collagen DNA in sera was quantitative using our method. The levels of serum α1(I) collagen DNA were significantly increased in scleroderma patients compared with healthy control subjects or systemic lupus erythematosus patients. According to the receiver-operator curve analysis, serum α1(I) collagen DNA levels were shown to be effective as a diagnostic marker of scleroderma. Furthermore, when we determined the association of serum α1(I) collagen DNA levels with clinical / laboratory features in scleroderma patients, those with elevated α1(I) collagen DNA levels showed significantly higher prevalence of pitting scars / ulcers. In summary, elevation of serum α1(I) collagen DNA levels in scleroderma patients may be useful as the diagnostic marker, reflecting the presence of vasculopathy. Jou rna
28370352	0	5	Serum	T031	C0229671
28370352	6	12	levels	T080	C0441889
28370352	16	27	genomic DNA	T114	C3272453
28370352	31	45	α1(I) collagen	T028	C1332772
28370352	50	58	elevated	T080	C3163633
28370352	62	73	scleroderma	T047	C0011644
28370352	74	82	patients	T101	C0030705
28370352	126	139	nucleic acids	T114,T123	C0028606
28370352	155	160	human	T016	C0086418
28370352	161	165	sera	T031	C0229671
28370352	220	235	disease markers	T078	C1511983
28370352	244	249	human	T016	C0086418
28370352	250	258	diseases	T047	C0012634
28370352	317	320	DNA	T114,T123	C0012854
28370352	325	328	RNA	T114	C0035668
28370352	332	341	collagens	T028	C1333079
28370352	351	356	human	T016	C0086418
28370352	357	361	sera	T031	C0229671
28370352	392	397	serum	T031	C0229671
28370352	398	404	levels	T080	C0441889
28370352	419	429	biomarkers	T201	C0005516
28370352	433	444	scleroderma	T047	C0011644
28370352	445	453	patients	T101	C0030705
28370352	459	462	RNA	T114	C0035668
28370352	466	469	DNA	T114,T123	C0012854
28370352	473	482	collagens	T028	C1333079
28370352	488	496	purified	T169	C1998793
28370352	502	506	sera	T031	C0229671
28370352	512	520	detected	T033	C0442726
28370352	524	549	polymerase chain reaction	T063	C0032520
28370352	553	564	quantitated	T081	C1709793
28370352	568	603	real-time polymerase chain reaction	T063	C1709846
28370352	628	667	360 bases of full-length α1(I) collagen	T028	C1332772
28370352	668	671	DNA	T114,T123	C0012854
28370352	681	688	regions	T028	C0017337
28370352	694	702	detected	T033	C0442726
28370352	706	731	polymerase chain reaction	T063	C0032520
28370352	735	740	human	T016	C0086418
28370352	741	745	sera	T031	C0229671
28370352	756	770	α2(I) collagen	T028	C1332773
28370352	771	774	DNA	T114,T123	C0012854
28370352	776	790	α1(I) collagen	T028	C1332772
28370352	791	794	RNA	T114	C0035668
28370352	798	812	α2(I) collagen	T028	C1332773
28370352	813	816	RNA	T114	C0035668
28370352	822	836	not detectable	T033	C0243095
28370352	838	852	α1(I) Collagen	T028	C1332772
28370352	853	856	DNA	T114,T123	C0012854
28370352	860	864	sera	T031	C0229671
28370352	869	881	quantitative	T081	C0392762
28370352	904	910	levels	T080	C0441889
28370352	914	919	serum	T031	C0229671
28370352	920	934	α1(I) collagen	T028	C1332772
28370352	935	938	DNA	T114,T123	C0012854
28370352	958	967	increased	T081	C0205217
28370352	971	982	scleroderma	T047	C0011644
28370352	983	991	patients	T101	C0030705
28370352	1006	1021	healthy control	T080	C2986479
28370352	1022	1030	subjects	T098	C0080105
28370352	1034	1062	systemic lupus erythematosus	T047	C0024141
28370352	1063	1071	patients	T101	C0030705
28370352	1090	1122	receiver-operator curve analysis	T081	C0035787
28370352	1124	1129	serum	T031	C0229671
28370352	1130	1144	α1(I) collagen	T028	C1332772
28370352	1145	1148	DNA	T114,T123	C0012854
28370352	1149	1155	levels	T080	C0441889
28370352	1188	1205	diagnostic marker	T201	C1511876
28370352	1209	1220	scleroderma	T047	C0011644
28370352	1258	1269	association	T080	C0439849
28370352	1273	1278	serum	T031	C0229671
28370352	1279	1293	α1(I) collagen	T028	C1332772
28370352	1294	1297	DNA	T114,T123	C0012854
28370352	1298	1304	levels	T080	C0441889
28370352	1310	1318	clinical	T080	C0205210
28370352	1321	1331	laboratory	T073,T093	C0022877
28370352	1332	1340	features	T080	C1521970
28370352	1344	1355	scleroderma	T047	C0011644
28370352	1356	1364	patients	T101	C0030705
28370352	1377	1385	elevated	T080	C3163633
28370352	1386	1400	α1(I) collagen	T028	C1332772
28370352	1401	1404	DNA	T114,T123	C0012854
28370352	1405	1411	levels	T080	C0441889
28370352	1440	1450	prevalence	T081	C0220900
28370352	1454	1467	pitting scars	T047	C0012634
28370352	1470	1476	ulcers	T047	C0041582
28370352	1490	1499	elevation	T080	C3163633
28370352	1503	1508	serum	T031	C0229671
28370352	1509	1523	α1(I) collagen	T028	C1332772
28370352	1524	1527	DNA	T114,T123	C0012854
28370352	1528	1534	levels	T080	C0441889
28370352	1538	1549	scleroderma	T047	C0011644
28370352	1550	1558	patients	T101	C0030705
28370352	1580	1597	diagnostic marker	T201	C1511876
28370352	1626	1638	vasculopathy	T047	C0042373
28370352	1644	1647	rna	T114	C0035668